Journal article
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
Abstract
BackgroundThe adoption of docetaxel for systemic treatment of metastatic prostate cancer (PCa), in both castration-sensitive (mCSPC) and castration-resistant (mCRPC) settings, is poorly understood. This study examined the real-world utilization of docetaxel in these patients and their outcomes.MethodsA retrospective population-based study used administrative data from Ontario, Canada, to identify men aged ≥66 years who were diagnosed with de …
Authors
Shayegan B; Wallis CJD; Hamilton RJ; Morgan SC; Cagiannos I; Basappa NS; Ferrario C; Gotto GT; Fernandes R; Roy S
Journal
Prostate Cancer and Prostatic Diseases, Vol. 26, No. 1, pp. 74–79
Publisher
Springer Nature
Publication Date
March 2023
DOI
10.1038/s41391-022-00514-9
ISSN
1365-7852